News
FDA advisory committee recommends approval of Healio
www.healio.com
May 27, — Committee member David M. Nathan, MD, director of the Massachusetts General Hospital Diabetes Center and professor of medicine at Harvard ... Mar 15, — David M. Nathan. The addition of SGLT2 inhibitors or GLP-1 receptor agonists — currently FDA approved only for type 2 diabetes — to ... › news › endocrinology › fda-ad... › news › endocrinology › cv-ben...
Harvard investigator joins UTSW colleagues in diabetes battle ...
www.utsouthwestern.edu
Feb 19, — Dr. David M. Nathan, Director of the General Clinical Research Center and the Diabetes Center at Massachusetts General Hospital, ... › articles › year-2016
The NIH is abandoning vital clinical research. That's a mistake
www.statnews.com
Jun 6, — David M. Nathan, MD, is director of the General Clinical Research Center of the Diabetes Center at Massachusetts General Hospital and professor ... › › nih-clinical-r...
Opinion: How to regulate pot when it's legal - CNN
edition.cnn.com
David Nathan says pot is going to be legal; let's consider the concerns of both advocates and opponents to come up with regulations.
sorted by relevance / date